Home > Boards > US Listed > Biotechs > Aclaris Therapeutics, Inc. (ACRS)

* * $ACRS Video Chart 10-07-2019 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 9,205
Posts 264,734
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2022 5:01:38 PM
Aclaris falls on the exit of medical chief Seeking Alpha - 1/11/2022 4:45:25 PM
Aclaris Therapeutics Provides R&D Update GlobeNewswire Inc. - 1/11/2022 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2022 4:35:40 PM
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference GlobeNewswire Inc. - 12/27/2021 7:00:00 AM
H.C. Wainwright Reaffirms Their Buy Rating on Aclaris Therapeutics (ACRS) TipRanks - 12/21/2021 2:11:21 AM
Leerink Partners Reiterates a Buy Rating on Aclaris Therapeutics (ACRS) TipRanks - 12/9/2021 2:38:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2021 7:03:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2021 4:53:32 PM
Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine GlobeNewswire Inc. - 12/3/2021 7:00:00 AM
Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021 GlobeNewswire Inc. - 11/18/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2021 4:19:41 PM
Aclaris Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 11/3/2021 7:00:00 AM
Aclaris Therapeutics EPS misses by $0.07, misses on revenue Seeking Alpha - 11/2/2021 7:40:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/2/2021 7:33:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2021 7:17:46 AM
Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 11/2/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 5:39:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2021 4:12:43 PM
Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action GlobeNewswire Inc. - 8/27/2021 4:01:00 PM
Aclaris Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 8/26/2021 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 7:32:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 7:16:31 AM
Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 4:02:07 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences